Article
Do circulating tumor cells, exosomes, and circulating tumor nucleic acids have clinical utility? A report of the association for molecular pathology.
The Journal of molecular diagnostics : JMD - 1 May 2015
Gold Bert, Cankovic Milena, Furtado Larissa V, Meier Frederick, Gocke Christopher D
Abstract excerpt
Diagnosing and screening for tumors through noninvasive means represent an important paradigm shift in precision medicine. In contrast to tissue biopsy, detection of circulating tumor cells (CTCs) and circulating tumor nucleic acids provides a minimally invasive method for predictive and prognostic marker detection. This allows early and serial assessment of metastatic disease, including follow-up during...
Topics
Join the communities discussing this publication.
